Dean J Mitchell Immuno Gen, Inc. (IMGN) insider trading activity

IMGN Quotes by TradingView

Dean J Mitchell is Director of ImmunoGen, Inc.. Currently has a direct ownership of 0 shares of IMGN, which is worth approximately $0. The most recent transaction as insider was on Feb 12, 2024, when has been sold 103,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
100.0% 12M change
Total Value Held $0

DEAN J MITCHELL Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 12 2024
SELL
Sale (or disposition) back to the issuer
-
103,000 Reduced 100.0%
0 Common Stock
Sep 22 2023
BUY
Exercise of conversion of derivative security
$147,000 $14.7 p/Share
10,000 Added 6.15%
152,667 Common Stock
Sep 03 2021
BUY
Exercise of conversion of derivative security
$273,070 $3.29 p/Share
83,000 Added 47.16%
93,000 Common Stock

Also insider at

PGEN
PRECIGEN, INC. Healthcare
Director
TBPH
Theravance Biopharma, Inc. Healthcare
PRAX
Praxis Precision Medicines, Inc. Healthcare
Director
KNTE
Kinnate Biopharma Inc. Healthcare
DJM

Dean J Mitchell

Director
Waltham, MA

Track Institutional and Insider Activities on IMGN

Follow ImmunoGen, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells IMGN shares.

Notify only if

Insider Trading

Get notified when an Immuno Gen, Inc. insider buys or sells IMGN shares.

Notify only if

News

Receive news related to ImmunoGen, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on IMGN